Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 sept. 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 17th Annual Global Investment Conference

CORAL GABLES, Fla., Sept. 03, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
17 août 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Paul J. Merrigan as Chief Commercial Officer

CORAL GABLES, Fla., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
10 août 2015 16h29 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
04 août 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Tuesday, August 11th, 2015

CORAL GABLES, Fla., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people...
22 juil. 2015 13h23 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)

CORAL GABLES, Fla., July 22, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
30 juin 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Dr. Gary Ingenito as Chief Medical Officer

CORAL GABLES, Fla., June 30, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
29 juin 2015 11h06 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes

CORAL GABLES, Fla., June 29, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
24 juin 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of Vigabatrin in Patients With Treatment-Refractory Tourette's Disorder

CORAL GABLES, Fla., June 24, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
28 mai 2015 11h20 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Names Richard J. Daly Interim Chief Commercial Officer

CORAL GABLES, Fla., May 28, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people...
27 mai 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference

CORAL GABLES, Fla., May 27, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people...

Page précédente

Page suivante